Post Job Free

Resume

Sign in

High Risk Patient Care

Location:
Paris, TN
Salary:
7.98
Posted:
December 30, 2023

Contact this candidate

Resume:

Summary of your answers

Questionnaire completed on 12/28/2023, 9:24 PM UTC

Pfizer Inc. (“Pfizer”), which manufactures and sells oral prescription medication for COVID-19, has contracted with Ada Health Inc. (“Ada”) for the development, hosting and operation of the questionnaire you completed. The questionnaire is intended to educate individuals about whether they meet current criteria for high risk for progression to severe COVID-19 and whether oral prescription medication for COVID-19 may be appropriate.

The questionnaire is not intended to influence the choice of treatment for severe COVID-19, and Pfizer has not made or offered any payment to Ada to influence the referral of patients to any Pfizer product. All decisions regarding patient care must be made in consultation with a healthcare professional, considering the unique characteristics of the patient. The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a healthcare professional. Pfizer will not receive any personal information relating to respondents or any of your individual responses. Ada will share with Pfizer only aggregated information related to responses to the questionnaire.

The questionnaire is only for US residents aged 18 or over. All guidance and recommendations follow current CDC, FDA, and NIH guidelines. If you have health concerns, talk to your healthcare professional. In a medical emergency, call 911.

Information you provided

The following information may not be comprehensive. A person’s risk of progression to severe COVID-19 increases with the number of underlying medical conditions. 40 to 49 years old

Mental health disorders limited to : Mood disorders including depression, Schizophrenia spectrum disorders

COVID-19 status you provided

Tested negative for COVID-19

No symptoms

Conclusion given

Your answers indicate you meet current criteria for being at high risk for progression to severe COVID-19 but are not eligible for oral prescription medication for COVID-19 at this time. Risk of severe illness from COVID-19 increases according to the number of underlying medical conditions a person has.

Oral prescription medications for COVID-19 are intended for people who: have been diagnosed with COVID-19, and

have mild-to-moderate symptoms of COVID-19 that started within the last 5 days, and are at high risk of progression to severe illness. If you are currently hospitalized due to severe COVID-19 or receiving supplemental oxygen as part of COVID-19 treatment, discuss the best treatment option with your healthcare professional. Guidance given

If you start to have symptoms, find out if oral prescription medication for COVID-19 is right for you within 5 days of your symptoms starting. Click here to learn how to contact a healthcare professional. Have a PDF summary of this questionnaire and a list of your current medications ready. It may help your healthcare professional decide what treatment is right for you. CDC recommends everyone stay up to date with COVID-19 vaccines for their age group. People who are moderately or severely immunocompromised have different recommendations for COVID-19 vaccines . Learn more about COVID-19 here . This guidance is based on CDC, FDA, and NIH guidelines. Useful links

CDC guidelines: https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with- medical-conditions.html

FDA guidelines: https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory- and-policy-framework/emergency-use-authorization NIH guidelines: https://www.covid19treatmentguidelines.nih.gov/ CDC COVID-19 vaccination guidance: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/stay-up-to- date.html and https://www.cdc.gov/coronavirus/2019- ncov/vaccines/recommendations/immuno.html

COVID-19 and managing your health: https://www.cdc.gov/coronavirus/2019-ncov/your- health/index.html

How to contact a healthcare professional: https://ada.com/covid/telehealth-consultation/

By accessing the links on this screen, you will be directed to a third-party website that is not maintained by Ada or Pfizer. Ada and Pfizer make no representations that the information in this site is accurate or up to date.



Contact this candidate